Antibiotics Are Generally NOT Recommended for Upper Respiratory Infections
Most upper respiratory infections (URIs) are viral and do not benefit from antibiotics—prescribing them causes harm without clinical benefit. 1, 2, 3
When Antibiotics Should NOT Be Used
The overwhelming majority of URIs are viral and resolve spontaneously within 7-10 days without antibiotic therapy. 1, 2, 3
Antibiotics are explicitly contraindicated for:
- Common cold (viral rhinitis) 2, 4
- Influenza 2
- COVID-19 2
- Laryngitis 2
- Nonspecific upper respiratory tract infections/acute rhinopharyngitis 3
Critical evidence: Antibiotic therapy for viral URIs does not shorten illness duration, does not prevent secondary bacterial infections, and only adds patient expense and risk of adverse reactions. 5, 3
The Rare Exception: Acute Bacterial Sinusitis
Only 0.5-2% of acute rhinosinusitis progresses to bacterial infection requiring antibiotics. 1
Antibiotics should ONLY be prescribed when acute bacterial rhinosinusitis (ABRS) is confirmed by one of three criteria: 6, 7
- Persistent symptoms ≥10 days without improvement
- Severe symptoms (fever ≥39°C with purulent nasal discharge and facial pain) for ≥3 consecutive days
- "Double sickening" - worsening after initial improvement from a viral URI
First-Line Antibiotic for Confirmed Bacterial Sinusitis
Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days is the preferred first-line agent for adults with confirmed ABRS. 6, 7
For Penicillin Allergy (Non-Severe)
Second- or third-generation cephalosporins are appropriate alternatives: 6
- Cefuroxime-axetil
- Cefpodoxime-proxetil
- Cefdinir
The risk of cross-reactivity between penicillins and second/third-generation cephalosporins is negligible in non-Type I allergies. 6
For Severe Penicillin Allergy (Anaphylaxis)
Respiratory fluoroquinolones should be reserved for documented severe β-lactam allergies: 6, 7
These provide 90-92% predicted clinical efficacy against drug-resistant Streptococcus pneumoniae and β-lactamase-producing Haemophilus influenzae. 6
Renal Dosing Adjustments
For levofloxacin in patients with impaired renal function, the FDA label provides specific guidance: 8
- The pharmacokinetics of levofloxacin are affected by renal impairment
- Dosage adjustments are required based on creatinine clearance
- Consult the full prescribing information for specific renal dosing recommendations
Essential Adjunctive Therapies (For All Patients)
These should be offered regardless of antibiotic use: 6, 7
- Intranasal corticosteroids (mometasone, fluticasone, or budesonide twice daily) - reduce inflammation and improve symptom resolution
- Saline nasal irrigation - provides symptomatic relief
- Analgesics (acetaminophen or ibuprofen) - for pain and fever
- Adequate hydration
Critical Pitfalls to Avoid
Do NOT prescribe antibiotics for symptoms lasting <10 days unless severe features are present (fever ≥39°C with purulent discharge for ≥3 consecutive days). 1, 6, 7
Purulent nasal discharge alone does NOT indicate bacterial infection - this is commonly observed in viral URIs and does not predict benefit from antibiotics. 3
Azithromycin and other macrolides should NEVER be used for respiratory infections due to resistance rates exceeding 20-25% for both S. pneumoniae and H. influenzae. 6
First-generation cephalosporins (cephalexin) are inappropriate due to inadequate coverage against Haemophilus influenzae. 6
Reassessment Timeline
If antibiotics are prescribed for confirmed ABRS: 6, 7
- Reassess at 3-5 days - if no improvement, switch to second-line therapy
- Reassess at 7 days - if symptoms persist or worsen, reconfirm diagnosis and consider complications
- Most patients should show noticeable improvement within 3-5 days of appropriate antibiotic therapy
The Bottom Line
The vast majority of URIs (98-99.5%) are viral and resolve spontaneously without antibiotics. 1, 7 Inappropriate antibiotic prescribing contributes to antimicrobial resistance, causes adverse effects, and adds unnecessary costs without clinical benefit. 1, 2, 5 Reserve antibiotics exclusively for the rare cases of confirmed acute bacterial sinusitis meeting strict diagnostic criteria. 1, 6, 7